Workflow
Reuters
icon
Search documents
Boeing seeks FAA emissions waiver to sell 35 additional 777F freighters
Reuters· 2025-12-19 22:53
Core Viewpoint - Boeing has requested a waiver from the Federal Aviation Administration (FAA) regarding airplane emissions rules to facilitate the sale of an additional 35 Boeing 777F freighters, driven by strong customer demand and delays in production [1] Group 1 - Boeing is experiencing strong customer demand for its 777F freighters, prompting the request for regulatory flexibility [1] - The request for a waiver is specifically aimed at addressing delays in production that could impact sales [1]
Musk wins appeal and restores 2018 Tesla pay deal worth $56 billion
Reuters· 2025-12-19 21:27
Core Points - The Delaware Supreme Court restored Elon Musk's 2018 pay package from Tesla, which was previously valued at $56 billion [1] - This decision comes two years after a lower court deemed the compensation deal "unfathomable" and struck it down [1] Company Summary - Elon Musk's compensation package was significant, originally worth $56 billion, indicating the scale of executive compensation in the tech and automotive industry [1] - The restoration of this pay package by the Delaware Supreme Court highlights ongoing legal and governance discussions surrounding executive compensation practices [1]
Medtronic's MiniMed files for US IPO
Reuters· 2025-12-19 21:16
Group 1 - MiniMed Group, the diabetes business of Medtronic, has filed for an initial public offering (IPO) in the United States [1]
US FDA approves Cytokinetics' heart disease drug
Reuters· 2025-12-19 21:08
Core Insights - The U.S. Food and Drug Administration has approved Cytokinetics' drug for treating a rare heart condition [1] Company Summary - Cytokinetics has received FDA approval for its drug, which targets a specific rare heart condition [1]
US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy
Reuters· 2025-12-19 21:03
Core Insights - The U.S. Food and Drug Administration (FDA) has granted national priority vouchers to Merck's cholesterol pill and cancer therapy, marking them as the latest additions to the fast-track program [1] Group 1: Company Developments - Merck's cholesterol pill and cancer therapy have received national priority vouchers from the FDA, which may expedite their development and approval process [1] Group 2: Industry Implications - The granting of national priority vouchers indicates a supportive regulatory environment for innovative therapies in the pharmaceutical industry, potentially leading to faster market access for new treatments [1]
Exclusive: BofA bonuses will jump for investment bankers this year, sources say
Reuters· 2025-12-19 20:15
Group 1 - Bank of America plans to increase bonus payouts for its top-performing investment bankers due to a significant rise in deal activity this year [1]
Starbucks taps Amazon's Anand Varadarajan as new chief technology officer
Reuters· 2025-12-19 19:20
Starbucks said on Friday it has appointed Anand Varadarajan as its new chief technology, effective January 19, as CEO Brian Niccol pushes a tech revamp in stores to make labor more efficient. ...
Bombardier's Global 8000 jet receives certification from US aviation regulator
Reuters· 2025-12-19 19:17
Bombardier's Global 8000 business jet, the world's fastest civilian plane since the Concorde, has received certification from the U.S. Federal Aviation Administration, the Canadian planemaker said on ... ...
Germany removes dividend ban for Uniper, paving way for IPO
Reuters· 2025-12-19 18:27
Germany on Friday passed a law that will enable Uniper to resume dividend payments, removing one of the main hurdles to Berlin's plan to re-list the utility that was bailed out during Europe's energy crisis. ...
Exclusive: AI chip firm Cerebras set to file for US IPO after delay, sources say
Reuters· 2025-12-19 18:11
AI chip maker Cerebras Systems is preparing to file for a U.S. initial public offering as soon as next week, targeting a second-quarter 2026 listing, people familiar with the matter said. ...